Activation of New ISIN for Sub-Division of Equity Shares of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Titan Biotech is effecting a sub-division (stock split) of its equity shares in the ratio of 1:5, where each existing share with a face value of Rs. 10 will be split into 5 equity shares of Rs. 2 each. A new ISIN, INE150C01029, has been activated to represent the post-split shares, with both NSDL and CDSL confirming the activation on February 4 and February 9, 2026, respectively. The record date for the sub-division has been fixed as February 20, 2026. The old ISIN (INE150C01011) will become inactive once the split takes effect. The split is purely structural and does not change the company's overall market capitalisation.
The stock split makes each share more affordable and can improve liquidity and retail participation, but does not change the intrinsic value of a shareholder's holdings. Investors holding shares as of the record date will automatically receive 5 shares of Rs. 2 for every 1 share of Rs. 10 held.